Validation of a Battery of Neuropsychological Tests for Patients With Metastatic Cancer

This study aimed to investigate the psychometric properties of Trail Making Test (TMT), Continuous Reaction Time (CRT), Finger Tapping Test (FTT), Digit Span Test (DST), and Mini-Mental State Examination (MMSE) in Brazilian patients with metastatic cancer. Cognitive performance of 178 patients with...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nursing research 2020-11, Vol.29 (8), p.607-615
Main Authors: Matuoka, Jessica Y., Kurita, Geana P., Nordly, Mie, Sjøgren, Per, de Mattos-Pimenta, Cibele A.
Format: Article
Language:English
Subjects:
Cancer
Clinical research
Cognitive ability
Cognitive functioning
Discriminant validity
Metastasis
Mini-Mental State Examination
Neuropsychological assessment
Nursing
Pain
Quantitative psychology
Reaction time
Reliability
Validity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study aimed to investigate the psychometric properties of Trail Making Test (TMT), Continuous Reaction Time (CRT), Finger Tapping Test (FTT), Digit Span Test (DST), and Mini-Mental State Examination (MMSE) in Brazilian patients with metastatic cancer. Cognitive performance of 178 patients with metastatic cancer and 79 controls was assessed using the TMT, CRT, FTT, DST, and MMSE. Discriminant validity, concurrent validity, and reliability (39 patients were retested after 3-7 days) were investigated. Discriminant validity between groups was observed in TMT, DST, and MMSE. Measures of concurrent validity and cognitive performance were positively correlated with physical performance, education level, and better performance on MMSE. Negative correlations were observed between cognitive function, pain, anxiety, and depression. All tests but FTT demonstrated very good reliability. Thus, all neuropsychological tests but FTT showed psychometric properties that permit their use in clinical and research purposes in patients with metastatic cancer.
ISSN:1054-7738
1552-3799
DOI:10.1177/1054773819831210